Dapagliflozin: A Review in Symptomatic Heart Failure with Reduced Ejection Fraction
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-187X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Dapagliflozin: A Review in Symptomatic Heart Failure with Reduced Ejection Fraction ; volume:21 ; number:6 ; day:15 ; month:10 ; year:2021 ; pages:701-710 ; date:11.2021
American journal of cardiovascular drugs ; 21, Heft 6 (15.10.2021), 701-710, 11.2021
- Urheber
-
Blair, Hannah A.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40256-021-00503-8
- URN
-
urn:nbn:de:101:1-2022020608253331645693
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:31 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Blair, Hannah A.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Correction to: Dapaglifozin: A Review in Symptomatic Heart Failure with Reduced Ejection Fraction
Vericiguat for Heart Failure with Reduced Ejection Fraction
Dapagliflozin for Heart Failure with Preserved Ejection Fraction: Will the DELIVER Study Deliver?
Cost-effectiveness analysis of dapagliflozin in the management of heart failure with reduced ejection fraction (HFrEF): a systematic review
SGLT2 inhibitors in heart failure with reduced ejection fraction
Heart Failure with Reduced Ejection Fraction—Does Sex Matter?
Improvement in left ventricular ejection fraction after pharmacological up-titration in new-onset heart failure with reduced ejection fraction
Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial
Right ventricular ejection fraction
Contemporary Drug Treatment of Advanced Heart Failure with Reduced Ejection Fraction
Genetic architecture of heart failure with preserved versus reduced ejection fraction
Anticoagulants for stroke prevention in heart failure with reduced ejection fraction
Correction to: Dapaglifozin: A Review in Symptomatic Heart Failure with Reduced Ejection Fraction
Vericiguat for Heart Failure with Reduced Ejection Fraction
Dapagliflozin for Heart Failure with Preserved Ejection Fraction: Will the DELIVER Study Deliver?
Cost-effectiveness analysis of dapagliflozin in the management of heart failure with reduced ejection fraction (HFrEF): a systematic review
SGLT2 inhibitors in heart failure with reduced ejection fraction
Heart Failure with Reduced Ejection Fraction—Does Sex Matter?
Improvement in left ventricular ejection fraction after pharmacological up-titration in new-onset heart failure with reduced ejection fraction
Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial
Right ventricular ejection fraction
Contemporary Drug Treatment of Advanced Heart Failure with Reduced Ejection Fraction
Genetic architecture of heart failure with preserved versus reduced ejection fraction
Anticoagulants for stroke prevention in heart failure with reduced ejection fraction
Correction to: Dapaglifozin: A Review in Symptomatic Heart Failure with Reduced Ejection Fraction
Vericiguat for Heart Failure with Reduced Ejection Fraction
Dapagliflozin for Heart Failure with Preserved Ejection Fraction: Will the DELIVER Study Deliver?
Cost-effectiveness analysis of dapagliflozin in the management of heart failure with reduced ejection fraction (HFrEF): a systematic review
SGLT2 inhibitors in heart failure with reduced ejection fraction
Heart Failure with Reduced Ejection Fraction—Does Sex Matter?
Improvement in left ventricular ejection fraction after pharmacological up-titration in new-onset heart failure with reduced ejection fraction
Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial
Right ventricular ejection fraction
Contemporary Drug Treatment of Advanced Heart Failure with Reduced Ejection Fraction
Genetic architecture of heart failure with preserved versus reduced ejection fraction